This study (n = 142) | Weber 2016 (n = 151) | Paris D’Orsay (n = 34) | Heidelberg (n = 155) | |
---|---|---|---|---|
Age (years) | 42 | 43 (mean) | 59 | 48 |
GTV (cc) | 26 | 35 | 24 | 70 (PTV) |
Treatment for recurrence (%) | 15 | 36 | 44 | 35 |
GTR (%) | 13 | 4 | 9 | 0 |
LC (%) | 75 (at 5 y) | 76 (at 5 y) | 83 (at 3 y) | 72 (at 5 y) |
OS (%) | 83 (at 5 y) | 86 (at 5 y) | 91 (at 3 y) | 85 (at 5 y) |